Cargando…

Deferasirox-Dependent Iron Chelation Enhances Mitochondrial Dysfunction and Restores p53 Signaling by Stabilization of p53 Family Members in Leukemic Cells

Iron is crucial to satisfy several mitochondrial functions including energy metabolism and oxidative phosphorylation. Patients affected by Myelodysplastic Syndromes (MDS) and acute myeloid leukemia (AML) are frequently characterized by iron overload (IOL), due to continuous red blood cell (RBC) tran...

Descripción completa

Detalles Bibliográficos
Autores principales:	Calabrese, Chiara, Panuzzo, Cristina, Stanga, Serena, Andreani, Giacomo, Ravera, Silvia, Maglione, Alessandro, Pironi, Lucrezia, Petiti, Jessica, Shahzad Ali, Muhammad, Scaravaglio, Patrizia, Napoli, Francesca, Fava, Carmen, De Gobbi, Marco, Frassoni, Francesco, Saglio, Giuseppe, Bracco, Enrico, Pergolizzi, Barbara, Cilloni, Daniela
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7589297/ https://www.ncbi.nlm.nih.gov/pubmed/33081324 http://dx.doi.org/10.3390/ijms21207674

Ejemplares similares

Mitochondria: A Galaxy in the Hematopoietic and Leukemic Stem Cell Universe
por: Panuzzo, Cristina, et al.
Publicado: (2020)

mTORC2 Is Activated under Hypoxia and Could Support Chronic Myeloid Leukemia Stem Cells
por: Panuzzo, Cristina, et al.
Publicado: (2023)

The Downregulation of Both Giant HERCs, HERC1 and HERC2, Is an Unambiguous Feature of Chronic Myeloid Leukemia, and HERC1 Levels Are Associated with Leukemic Cell Differentiation
por: Ali, Muhammad Shahzad, et al.
Publicado: (2022)

Reduced Expression of Sprouty1 Contributes to the Aberrant Proliferation and Impaired Apoptosis of Acute Myeloid Leukemia Cells
por: Rosso, Valentina, et al.
Publicado: (2019)

Curcumin induces apoptosis in JAK2‐mutated cells by the inhibition of JAK2/STAT and mTORC1 pathways
por: Petiti, Jessica, et al.
Publicado: (2019)

Genetic Screening for Potential New Targets in Chronic Myeloid Leukemia Based on Drosophila Transgenic for Human BCR-ABL1
por: Lo Iacono, Marco, et al.
Publicado: (2021)

The Giant HECT E3 Ubiquitin Ligase HERC1 Is Aberrantly Expressed in Myeloid Related Disorders and It Is a Novel BCR-ABL1 Binding Partner
por: Ali, Muhammad Shahzad, et al.
Publicado: (2021)

Bcl‐xL represents a therapeutic target in Philadelphia negative myeloproliferative neoplasms
por: Petiti, Jessica, et al.
Publicado: (2020)

Digital PCR in Myeloid Malignancies: Ready to Replace Quantitative PCR?
por: Cilloni, Daniela, et al.
Publicado: (2019)

Standardization of BCR-ABL1 p210 Monitoring: From Nested to Digital PCR
por: Jovanovski, Aleksandar, et al.
Publicado: (2020)

Variable but consistent pattern of Meningioma 1 gene (MN1) expression in different genetic subsets of acute myelogenous leukaemia and its potential use as a marker for minimal residual disease detection
por: Carturan, Sonia, et al.
Publicado: (2016)

A Leukemic Target with a Thousand Faces: The Mitochondria
por: Maffeo, Beatrice, et al.
Publicado: (2023)

P998: REGULATION OF BCL-X SPLICING BY SRC KINASES INHIBITORS IN MYELOPROLIFERATIVE NEOPLASMS
por: Petiti, J., et al.
Publicado: (2022)

Detection of BCR-ABL T315I mutation by peptide nucleic acid directed PCR clamping and by peptide nucleic acid FISH
por: Rosso, Valentina, et al.
Publicado: (2015)

Highly Sensitive Detection of IDH2 Mutations in Acute Myeloid Leukemia
por: Petiti, Jessica, et al.
Publicado: (2020)

Landscape of Tumor Suppressor Mutations in Acute Myeloid Leukemia
por: Panuzzo, Cristina, et al.
Publicado: (2020)

Mechanisms of p53 Functional De-Regulation: Role of the IκB-α/p53 Complex
por: Carrà, Giovanna, et al.
Publicado: (2016)

CITED2 affects leukemic cell survival by interfering with p53 activation
por: Mattes, Katharina, et al.
Publicado: (2017)

Novel Multiplex Droplet Digital PCR Assays to Monitor Minimal Residual Disease in Chronic Myeloid Leukemia Patients Showing Atypical BCR-ABL1 Transcripts
por: Petiti, Jessica, et al.
Publicado: (2020)

The anti-leukemic activity of sodium dichloroacetate in p53(mutated/null) cells is mediated by a p53-independent ILF3/p21 pathway
por: Agnoletto, Chiara, et al.
Publicado: (2014)

Detection of SF3B1 p.Lys700Glu Mutation by PNA-PCR Clamping in Myelodysplastic Syndromes and Myeloproliferative Neoplasms
por: Petiti, Jessica, et al.
Publicado: (2022)

Iron overload alters the energy metabolism in patients with myelodysplastic syndromes: results from the multicenter FISM BIOFER study
por: Cilloni, Daniela, et al.
Publicado: (2020)

The p53 family reaches the final frontier: the variegated regulation of the dark matter of the genome by the p53 family in cancer
por: Napoli, Marco, et al.
Publicado: (2020)

A novel assay to detect calreticulin mutations in myeloproliferative neoplasms
por: Rosso, Valentina, et al.
Publicado: (2016)

Involvement of p53 in the cytotoxic activity of the NAMPT inhibitor FK866 in myeloid leukemic cells
por: Thakur, Basant Kumar, et al.
Publicado: (2013)

Anti-leukemic properties of deferasirox via apoptosis in murine leukemia cell lines
por: Jeon, Sol-Rim, et al.
Publicado: (2015)

p53 isoforms change p53 paradigm
por: Bourdon, JC
Publicado: (2014)

Unfolded p53 in the pathogenesis of Alzheimer's disease: is HIPK2 the link?
por: Stanga, Serena, et al.
Publicado: (2010)

A small molecule p53 activator attenuates Fanconi anemia leukemic stem cell proliferation
por: Du, Wei, et al.
Publicado: (2018)

p53 β-hydroxybutyrylation attenuates p53 activity
por: Liu, Kun, et al.
Publicado: (2019)

Understanding p53 functions through p53 antibodies
por: Sabapathy, Kanaga, et al.
Publicado: (2019)

p53’s Extended Reach: The Mutant p53 Secretome
por: Pavlakis, Evangelos, et al.
Publicado: (2020)

Revealing the Mysteries of Acute Myeloid Leukemia: From Quantitative PCR through Next-Generation Sequencing and Systemic Metabolomic Profiling
por: Panuzzo, Cristina, et al.
Publicado: (2022)

Design and application of a novel PNA probe for the detection at single cell level of JAK2(V617F) mutation in Myeloproliferative Neoplasms
por: Bracco, Enrico, et al.
Publicado: (2013)

D133P53, directly transactivated by p53, prevents p53-mediated apoptosis without inhibiting p53-mediated cell cycle arrest
por: Aoubala, M, et al.
Publicado: (2010)

Non genomic loss of function of tumor suppressors in CML: BCR-ABL promotes IκBα mediated p53 nuclear exclusion
por: Crivellaro, Sabrina, et al.
Publicado: (2015)

OTUD5 Regulates p53 Stability by Deubiquitinating p53
por: Luo, Judong, et al.
Publicado: (2013)

The Δ133p53 Isoforms, Tuners of the p53 Pathway
por: Joruiz, Sebastien M., et al.
Publicado: (2020)

Corrigendum to ‘Understanding p53 functions through p53 antibodies’
por: Sabapathy, Kanaga, et al.
Publicado: (2019)

JAK2V617F and p53 mutations coexist in erythroleukemia and megakaryoblastic leukemic cell lines
por: Zhao, Wanke, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_fm98u0a2emm1jmbu3k9a2br02i